Haemonetics Vascade MVP XL Vascular Closure Device Introduced

June 18, 2024––Haemonetics Corporation announced it commenced a limited market release of its Vascade MVP XL midbore venous closure device. The device is part of the company’s Vascade portfolio of vascular closure systems featuring Haemonetics collapsible disc technology and a resorbable collagen patch designed to promote rapid hemostasis.

The company advised that the Vascade MVP XL system received premarket approval from the FDA earlier this spring. The limited market release comes after the first procedure using the system, which was performed by Tom McElderry, MD, Section Chief, Electrophysiology and Co-Director Heart & Vascular Center at the University of Alabama at Birmingham in Birmingham, Alabama.

According to Haemonetics, its current Vascade portfolio includes the Vascade system, which is designed for small-bore femoral arterial and venous closure with standard 5- to 6/7-F procedural sheaths; and the Vascade MVP system, which is designed for midbore multiaccess femoral venous closure with 6- to 12-F procedural sheaths.

The upsized Vascade MVP XL system utilizes 58% more collagen and a larger disc than the current Vascade MVP system for procedures requiring 10- to 12-F sheaths (up to 15-F in outer diameter) such as cryoablation and left atrial appendage closure for atrial fibrillation patients, stated Haemonetics.